MORISHITA JINTAN CO.,LTD.

4524 TSE Pharmaceuticals Pharmaceutical
TSE Standard
¥2,243.00
+0.27%
Delayed · cached 15 min

Fair value analysis

4524
MORISHITA JINTAN CO.,LTD.
PharmaceuticalsPharmaceutical
¥2,243.00
Close used for this calculation
¥3,399.34Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
69/100
Profitability17/25
Returns13/25
Balance Sheet21/25
Efficiency18/25
Growth23/25
Strong
Quality radar
69Prof.17/25Ret.13/25Eff.18/25B.Sht21/25Growth23/25

Consensus fair value

¥3,399.34
Below FV
▲ +51.6% against the close used
Model range ¥87.35 – ¥5,299.72
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥87.35Fair value¥3,399.34Bull¥5,299.72
FairClose
52-week traded range
52W low ¥2,105.0052W high ¥2,360.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

MORISHITA JINTAN CO.,LTD. closed at ¥2,243.00, 34.0% below the consensus fair value of ¥3,399.34 drawn from 9 valuation models.

Financial DNA score 69/100 — Strong. P/E of 14.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥87.35
-96.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥3,303.49
+47.3%
√(22.5 × EPS × BVPS)
EPS=153.53, BVPS=3159.15
P/E Fair Value
¥3,070.60
+36.9%
EPS × 20x (sector P/E)
EPS=153.53, Sector P/E=20x
Peter Lynch (PEG)
¥3,385.34
+50.9%
EPS × Growth% (PEG = 1 is fair)
EPS=153.53, g=22.1%
EV/EBITDA
¥5,299.72
+136.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=1.29B
Dividend Discount (DDM)
¥3,512.54
+56.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=65.05, r=10%, g=8%
Book Value (P/B)
¥1,579.58
-29.6%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3159.15, ROE=5%, g=6%, r=10%
Reverse DCF
¥2,243.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.9% | Historical: 22.1%
Margin of Safety
¥1,615.36
-28.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2153.81, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.